FierceBiotech 22 avr. 2026 Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Insilico Medicine 21 avr. 2026 Insilico Medicine and Eli Lilly and Company Partner on AI-Driven Drug Discovery - CDO Magazine
BioPharma Dive 17 avr. 2026 Lilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
BioPharma Dive 8 avr. 2026 Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
FierceBiotech 7 avr. 2026 Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic
Endpoints News 2 avr. 2026 Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
Endpoints News 2 avr. 2026 Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News 1 avr. 2026 Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
FierceBiotech 31 mars 2026 Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play